BURLINGAME, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced the publication of preclinical data ...
A lecturer at the Olusegun Agagu University of Science and Technology (OAUSTECH), Okitipupa, Ondo State, Dr. Cecilia Oluwamodupe has received a patent certificate for her innovative research invention ...
Hosted on MSN
Shuttle Pharmaceuticals’ terminated glioblastoma trial: What investors need to know now
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) announced an update on their ongoing clinical study. Study Overview Shuttle Pharmaceuticals Holdings, Inc. is running a Phase 2 trial titled “Phase 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results